AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Bloomberg Businessweek Weekend - April 28th, 2023
Bloomberg Businessweek
The Risks and Benefits of Ozempic Wigovi
3min Snip
00:00
Summary
Transcript
Episode notes
There are a number of less well-known drugs, including one called Muñjaro that hasn't been formally approved for obesity. There's also a drug called Wigovi, which was the first highly effective obesity drug approved in the US. All drugs are not without risks, including nausea, vomiting, and diarrhea,. And you actually have to titrate them up slowly. They're way more effective than anything that had been available for weight loss before. It's getting a lot of doctors and patients excited about it.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode